Visiopharm announces Ralf Huss as chairperson of the scientific advisory board

Visiopharm is very happy to announce that Ralf Huss, M.D, Ph.D. has been appointed as the chairperson of their scientific advisory board. As the new academic leader of the advisory board, he brings a wealth of scientific and industry leadership experience in digital pathology. 

Currently, Ralf Huss is a Professor of Pathology and the managing deputy director of Pathology and Molecular Diagnostics at the University Hospital in Augsburg (Germany), where he also leads the Center for Digital Medicine. He is board-certified in anatomical, experimental, and molecular pathology with more than 30 years of experience in histopathology, immunology, cancer research and oncology.

“The interplay between the scientific community and companies like Visiopharm represents an essential partnership that helps drive advances in digital pathology. In particular, the need for communication between these two worlds is evident during these extraordinary times. For my part, I am looking forward to developing an international board of advisors that ensures Visiopharm continues to lead the field with technologies and partnerships that bring value to the field.”

His advisory role will begin on May 1, 2020, and among his responsibilities will be structuring the advisory board with a particular focus on guidance in the areas of clinical pathology and quality management of pathological workflows.

“I couldn’t be more pleased to have Ralf join as chairperson of our scientific advisory board. Building a strong advisory board ensures that we maintain close ties to the community and create solutions that pathologists need. With his practical experience and connections in the digital pathology field, Ralf will be instrumental in guiding the future success of Visiopharm.”

– Michael Grunkin PhD, CEO at Visiopharm